This review aimed to provide an overview of the level of maturity of normal tissue complication probability (NTCP) models for head and neck cancer (HNC) patients. A …
S Michiels, K Poels, W Crijns, L Delombaerde… - Radiotherapy and …, 2018 - Elsevier
Background and purpose Linac improvements in gantry speed, leaf speed and dose rate may increase the time-efficiency of volumetric modulated arc therapy (VMAT) delivery. The …
BA Miles, MR Posner, V Gupta, MS Teng… - The …, 2021 - academic.oup.com
Background Treatment of human papillomavirus-related oropharyngeal squamous cell carcinoma (HPVOPC) results in unprecedented high survival rates but possibly unnecessary …
TP Schrank, L Landess, WH Stepp, H Rehmani… - Molecular Cancer …, 2022 - AACR
Abstract Human papillomavirus–positive (HPV+) squamous cell carcinoma of the oropharynx (OPSCC) is the most prevalent HPV-associated malignancy in the United States …
CC Mireștean, RI Iancu, DPT Iancu - International Journal of …, 2022 - mdpi.com
The evolution and development of radiotherapy in the last two decades has meant that postgraduate medical training has not kept up with this rapid progress both in terms of …
Background Human papillomavirus–positive (HPV+) squamous cell carcinoma of the oropharynx (OPSCC) is the most prevalent HPV‐associated malignancy in the United …
M Svajdova, P Dubinsky, T Kazda, B Jeremic - Cancers, 2022 - mdpi.com
Simple Summary Current options for the curative treatment of the non-metastatic oropharyngeal carcinoma associated with human papillomavirus include minimally-invasive …
P Mavroidis, KA Pearlstein, J Dooley, J Sun… - Radiation …, 2018 - Springer
Background To estimate the radiobiological parameters of three popular normal tissue complication probability (NTCP) models, which describe the dose-response relations of …
S Madhavan, M Gamez, YI Garces, SC Lester… - Frontiers in …, 2024 - frontiersin.org
Objectives To investigate the relationship between nutritional supplementation and radiation dose to the pharyngeal constrictor muscles and larynx for head and neck (HN) cancer …